Loading
₹2,012.90
−16.40−0.81%today
Market closed · 7 Oct, 3:30 pm
+4.58%over 1 year
Today's range
₹2,001.50₹2,030.80
52-week range
₹1,900.00₹2,529.50
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 27,488 | 5,333 | 19.4% | 116.44 |
| FY25 | 22,192 | 3,282 | 14.8% | 71.69 |
| FY24 | 19,656 | 1,914 | 9.7% | 41.87 |
| FY23 | 16,270 | 430 | 2.6% | 9.41 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 46.85% | 46.86% | 46.89% | 46.90% |
| FIIs | 22.42% | 21.71% | 21.49% | 20.49% |
| DIIs | 24.65% | 25.32% | 25.58% | 26.55% |
| of which mutual funds | 14.84% | 16.93% | 18.01% | 20.57% |
| Government | 0.00% | 0.00% | 0.01% | 0.01% |
| Public | 6.08% | 6.11% | 6.03% | 6.06% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Laurus Labs Ltd.LAURUSLABS | 2,052.80 | +0.14% | 1,10,915 |
| Cipla Ltd.CIPLA | 1,327.20 | −0.97% | 1,07,221 |
| Mankind Pharma Ltd.MANKIND | 2,500.00 | 0.00% | 1,03,261 |
| Dr. Reddy's Laboratories Ltd.DRREDDY | 1,203.80 | −0.35% | 1,00,476 |
| Aurobindo Pharma Ltd.AUROPHARMA | 1,682.00 | −0.64% | 96,779 |
| Lupin Ltd.LUPIN · this stock | 2,012.90 | −0.81% | 92,048 |
| Max Healthcare Institute Ltd.MAXHEALTH | 908.00 | +0.61% | 88,377 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.